Stocks climb for third consecutive session, Nifty surpasses 25,000 level
Among sectoral indices, Nifty IT was the top performer, up 2%, as the market geared up for the start of the earnings season.
Latest News
JNK India wins ₹1,000+ crore ultra-mega contract from Korean promoter JNK Global
The order, classified as ultra-mega with a value exceeding ₹1,000 crore, has been awarded by JNK Global, an international entity and one of the promoters…
Trent shares fall 4% from day’s high: Here’s what its Q2 update said
Tata Group’s Trent Ltd posted a 17% year-on-year rise in standalone revenue to ₹5,002 crore for Q2 FY26, expanding its store network with 53 new…
HCLTech partners with MIT Media Lab to advance next-gen AI and emerging tech research
As part of this engagement, HCLTech will gain access to the MIT Media Lab’s extensive research resources and innovation networks. This will enable deeper collaboration…
Zydus Lifesciences wins USFDA nod for deflazacort suspension to treat DMD in children
Deflazacort oral suspension is indicated for the treatment of Duchenne Muscular Dystrophy (DMD) in patients aged five years and older. Shares of Zydus Lifesciences Ltd…
KEC International bags orders worth ₹1,102 crore across segments
KEC International secured new orders worth ₹1,102 crore across civil, transportation, T&D and cables businesses, boosting its YTD order intake to nearly ₹12,800 crore, with…
Gold and silver prices may crash soon, a wealth manager says
Gold prices have hit multiple all-time highs this year, currently hovering near the $4,000 mark for each ounce, while silver is near $50 level.
Here’s why Premier Explosives shares are up 10% on Monday
Sources said an amendment has been made to the revenue procurement manual (RPM). This eliminates the previous requirement for private entities intending to manufacture bombs…
Tata Capital IPO: CEO addresses the margin question
The IPO is currently open for subscription.
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
Lilly’s investment plans in India come at a time when global drugmakers are rushing to bolster US manufacturing capacity after the Trump administration imposed a…